Back to Companies
Arbutus Biopharma Corp
ABUSNasdaqCIK: 0001447028
Over the 10 most recent insider filings, Arbutus Biopharma Corp (ABUS) has seen activity from 4 distinct insiders — no open-market buying or selling. Nguyen Tuan (Chief Financial Officer) is the most active by dollar volume, and the single largest transaction was $3.1M by Nguyen Tuan. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$7.4M
Purchases
$0
Sales
$0
Unique Insiders
4
Recent Insider Trades
10 loaded
| Sep 23 | ABUS Arbutus Biopharma Corp | Androski Lindsay | President and CEO, Director | Exercise | $1.3M |
| Sep 23 | ABUS Arbutus Biopharma Corp | Nguyen Tuan | Chief Financial Officer | Exercise | $3.1M |
| Sep 23 | ABUS Arbutus Biopharma Corp | Beardsley Robert A | Director | Exercise | $1.5M |
| Sep 23 | ABUS Arbutus Biopharma Corp | Sawhney Roger | Director | Exercise | $1.5M |
| Jun 10 | ABUS Arbutus Biopharma Corp | Beardsley Robert A | Director | Award | $0 |
| Jun 10 | ABUS Arbutus Biopharma Corp | Sawhney Roger | Director | Award | $0 |
| Feb 2 | ABUS Arbutus Biopharma Corp | Nguyen Tuan | Chief Financial Officer | Grant | $0 |
| Feb 2 | ABUS Arbutus Biopharma Corp | Androski Lindsay | President and CEO, Director | Grant | $0 |
| Aug 6 | ABUS Arbutus Biopharma Corp | Sawhney Roger | Director | Other | $0 |
| Aug 6 | ABUS Arbutus Biopharma Corp | Sawhney Roger | Director | Award | $0 |
10 filings